Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider-pharmacist collaborative drug therapy management practices and identifies the facilitators and barriers to implementing such services in community settings. We conducted in-depth, qualitative interviews in 2012 in a federally qualified health center, an independent pharmacy, and a retail pharmacy chain. Facilitators included 1) ensuring pharmacists were adequately trained; 2) obtaining stakeholder (eg, physician) buy-in; and 3) leveraging academic partners. Barriers included 1) lack of pharmacist compensation; 2) hesitation among providers to trust pharmacists; 3) lack of time and resources; and 4) existing informal collaborations that resulted in reduced interest in formal agreements. The models described in this study could be used to strengthen clinical-community linkages through team-based care, particularly for chronic disease prevention and management.
CITATION STYLE
Snyder, M. E., Earl, T. R., Gilchrist, S., Greenberg, M., Heisler, H., Revels, M., & Matson-Koffman, D. (2015). Collaborative drug therapy management: Case studies of three community-based models of care. Preventing Chronic Disease, 12(3). https://doi.org/10.5888/pcd12.140504
Mendeley helps you to discover research relevant for your work.